| 2026-05-07 | Mr. Glenn P. MuirIndependent Director | 2,43k | 94,34k | Derivative Exercise and Retained Stock | 38,76 | 38,08k | 6,83% |
| 2026-05-07 | Mr. Brian DouglassSenior VP & Chief Product Officer | -334,00 | 42,23k | Sale to Issuer | 126,43 | 1,61k | -17,20% |
| 2026-04-21 | Mr. Olivier LoeillotPresident, CEO & Director | -3,83k | 536,48k | Verkauf | 140,00 | 1,00 | -99,97% |
| 2026-03-04 | Mr. James R. BylundCOO | -62,00 | 7,80k | Sale to Issuer | 125,84 | 17,67k | -0,35% |
| 2026-03-04 | Mr. Ralf KuriyelSVP of Research & Development | -42,00 | 5,29k | Sale to Issuer | 125,84 | 14,78k | -0,28% |
| 2026-02-27 | Mr. James R. BylundCOO | -3,91k | 494,31k | Sale to Issuer | 124,97 - 128,73 | 8,28k | -32,09% |
| 2026-02-27 | Mr. Olivier LoeillotPresident, CEO & Director | -1,95k | 245,48k | Sale to Issuer | 124,97 - 128,73 | 33,94k | -5,44% |
| 2026-03-02 | Mr. Anthony J. HuntAdvisor | -9,90k | 1,24M | Sale to Issuer | 124,97 | 82,49k | -10,71% |
| 2026-02-27 | Mr. Jason K. GarlandCFO & CCO | -1,04k | 131,45k | Sale to Issuer | 124,97 - 128,73 | 3,90k | -21,07% |
| 2026-02-27 | Mr. Ralf KuriyelSVP of Research & Development | -1,37k | 172,50k | Sale to Issuer | 124,97 - 128,73 | 14,70k | -8,51% |
| 2026-03-02 | Mr. Brian DouglassSenior VP & Chief Product Officer | -221,00 | 27,62k | Sale to Issuer | 124,97 | 1,14k | -16,21% |
| 2025-12-17 | Ms. Karen Anne T. DawesLead Independent Director | -275,00 | 44,28k | Verkauf | 161,00 | 90,85k | -0,30% |
| 2025-12-16 | Mr. Glenn P. MuirIndependent Director | 3,37k | 87,92k | Derivative Exercise and Retained Stock | 26,12 | 35,65k | 10,43% |
| 2025-12-04 | Mr. Anthony J. HuntAdvisor | -2,00k | 0,00 | Other Disposition | - | 79,35k | -2,46% |
| 2025-11-25 | Mr. Olivier LoeillotPresident, CEO & Director | -7,04k | 1,20M | Verkauf | 170,00 | 0,00 | -100,00% |
| 2025-11-18 | Mr. James R. BylundCOO | -2,19k | 331,30k | Verkauf | 151,21 | 6,51k | -25,19% |
| 2025-11-13 | Mr. Anthony J. HuntAdvisor | 2,95k | 99,98k | Derivative Exercise and Retained Stock | 33,87 | 64,09k | 4,83% |
| 2025-11-13 | Mr. Anthony J. HuntAdvisor | -20,00k | 3,09M | Verkauf | 151,01 - 157,11 | 64,09k | -23,79% |
| 2025-11-12 | Mr. Anthony J. HuntAdvisor | -25,00k | 3,08M | Derivative Exercise and Sale | 33,87 - 158,51 | 81,13k | - |
| 2025-10-02 | Mr. Olivier LoeillotPresident, CEO & Director | -1,25k | 181,25k | Sale to Issuer | 145,23 | 7,04k | -15,06% |
| 2025-09-25 | Mr. Jason K. GarlandCFO & CCO | -412,00 | 50,13k | Sale to Issuer | 121,68 | 1,95k | -17,42% |
| 2025-09-10 | Mr. Anthony J. HuntAdvisor | -20,00k | 1,72M | Derivative Exercise and Sale | 33,87 - 121,42 | 81,13k | - |
| 2025-09-10 | Mr. Anthony J. HuntAdvisor | -9,11k | 1,11M | Verkauf | 121,42 - 122,23 | 81,13k | -10,10% |
| 2025-09-03 | Mr. Olivier LoeillotPresident, CEO & Director | -2,51k | 291,15k | Sale to Issuer | 116,18 | 5,71k | -30,51% |
| 2025-08-08 | Dr. Martin D. MadausIndependent Chair of the Board | 1,80k | 201,83k | Kauf | 112,13 | 6,42k | 38,93% |